Enteral Nutrition after Severe Burn

Clinical Nutrition

Volumn , Issue , 2005, Pages 349-363

  Woodside, Kenneth J ^a   Wolf, Steven E ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Blocker Burn Unit   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745665881     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0379-7.50032-2     Document Type: Chapter

References (142)

1. Newsome TW, Mason AD, Pruitt BA Weight loss following thermal injury. Ann Surg 1973, 178:215-217.
2. Cone JB, Pasley JN, Bond PJ, et al. Alteration in gastrointestinal peptides after thermal injury in humans. J Burn Care Rehabil 1993, 14:663-665.
3. Brizio-Molteni L, Molteni A, Warpeha RL, et al. Prolactin, corticotrophin, and gonadotropin concentrations following thermal injury in adults. J Trauma 1984, 24:1-7.
4. Vaughan GM, Becker RA, Allen JP, et al. Cortisol and corticotrophin in burned patients. J Trauma 1982, 22:263-273.
5. Molteni A, Warpeha RL, Brizio-Molteni L, et al. Circadian rhythms of serum aldosterone, cortisol and plasma renin activity in burn injuries. Ann Clin Lab Sci 1979, 9:518-523.
6. Wolfe RR, Herndon DN, Jahoor F, et al. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 1987, 317:403-408.
7. Hart DW, Wolf SE, Chinkes DL, et al. Determinants of skeletal muscle catabolism after severe burn. Ann Surg 2000, 232:455-465.
8. Gore DC, Chinkes D, Sanford A, et al. Influence of fever on the hypermetabolic response in burn-injured children. Arch Surg 2003, 138:169-174.
9. Wilmore DW, Long JM, Mason AD, et al. Catecholamines: Mediators of the hypermetabolic response in thermally burned patients. Ann Surg 1974, 180:653-659.
10. Milner EA, Cioffi WG, Mason AD, et al. A longitudinal study of resting energy expenditure in thermally injured patients. J Trauma 1994, 37:167-170.
11. Hart DW, Wolf SE, Mlcak R, et al. Persistence of muscle catabolism after severe burn. Surgery 2000, 128:312-319.
12. Stinnett JD, Alexander JW, Watanabe C, et al. Plasma and skeletal muscle amino acids following severe burn injury in patients and experimental animals. Ann Surg 1982, 195:75-89.
13. Kinney JM Metabolic response to injuries. Nutritional Support of the Seriously Ill Patient 1983, 5. Academic Press, New York. R.W. Winters, H.L. Greene (Eds.).
14. McClave SA, Mitoraj TE, Thielmeier KA, et al. Differentiating subtypes (hypoalbuminemic vs marasmic) of protein-calorie malnutrition: Incidence and clinical significance in a university hospital setting. JPEN J Parenter Enteral Nutr 1992, 16:337-342.
15. Sakurai Y, Aarsland A, Herndon DN, et al. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg 1995, 222:283-294.
16. Jahoor F, Desai M, Herndon DN, et al. Dynamics of the protein metabolic response to burn injury. Metabolism 1988, 37:330-337.
17. Shangraw RE, Stuart CA, Prince MJ, et al. Insulin responsiveness of protein metabolism in vivo following bedrest in humans. Am J Physiol 1988, 255(4):E548-E558. part 1.
18. Shaw JH, Wolfe RR An integrated analysis of glucose, fat, and protein metabolism in severely traumatized patients. Studies in the basal state and the response to total parenteral nutrition. Ann Surg 1989, 209:63-72.
19. Wolfe RR, Herndon DN, Peters EJ, et al. Regulation of lipolysis in severely burned children. Ann Surg 1987, 206:214-221.
20. Herndon DN, Wilmore DW, Mason AD, et al. Development and analysis of a small animal model stimulating the human postburn hypermetabolic response. J Surg Res 1978, 25:394-403.
21. Muller MJ, Meyer N, Herndon DN, et al. Nutritional support for the burned patient. Surgical Nutrition: Strategies in Critically Ill Patients 1995, 103. Springer-Verlag, New York. R. Latifi, S.J. Dudrick (Eds.).
22. Wolfe RR, Burke JF Effect of glucose infusion on glucose and lactate metabolism in normal and burned guinea pigs. J Trauma 1978, 18:800-805.
23. Michie HR, Wilmore DW Sepsis, signals, and surgical sequelae (a hypothesis). Arch Surg 1990, 125:531-536.
24. Vindenes HA, Ulvestad E, Bjerknes R Concentrations of cytokines in plasma of patients with large burns: Their relation to time after injury, burn size, inflammatory variables, infection, and outcome. Eur J Surg 1998, 164:647-656.
25. Furukawa K, Kobayashi M, Herndon DN, et al. Appearance of monocyte chemoattractant protein 1 (MCP-1) early after thermal injury: Role in the subsequent development of burn-associated type 2 T-cell responses. Ann Surg 2002, 236:112-119.
26. Marano MA, Fong Y, Moldawer LL, et al. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet 1990, 170:32-38.
27. 2 and immunomodulation with indomethacin. J Immunol 1993, 151:2142-2149.
28. Yeh FL, Lin WL, Shen HD, et al. Changes in serum tumor necrosis factor-alpha in burned patients. Burns 1997, 23:6-10.
29. Zhang B, Huang YH, Chen Y, et al. Plasma tumor necrosis factor-alpha, its soluble receptors and interleukin-1beta levels in critically burned patients. Burns 1998, 24:599-603.
30. Becker RA, Vaughan GM, Goodwin CW, et al. Plasma norepinephrine, epinephrine, and thyroid hormone interactions in severely burned patients. Arch Surg 1980, 115:439-443.
31. Gore DC, Chinkes DL, Hart DW, et al. Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med 2002, 30:2438-2442.
32. Bessey PQ, Watters JM, Aoki TT, et al. Combined hormonal infusion simulates the metabolic response to injury. Ann Surg 1984, 200:264-281.
33. Watters JM, Bessey PQ, Dinarello CA, et al. Both inflammatory and endocrine mediators stimulate host responses to sepsis. Arch Surg 1986, 121:179-190.
34. Aulick LH, Wilmore DW Increased peripheral amino acid release following burn injury. Surgery 1979, 85:560-565.
35. Clowes GH, Randall HT, Cha CJ Amino acid and energy metabolism in septic and traumatized patients. JPEN J Parenter Enteral Nutr 1980, 4:195-205.
36. Herndon DN, Wilmore DW, Mason AD, et al. Abnormalities of phenylalanine and tyrosine kinetics. Significance in septic and nonseptic burned patients. Arch Surg 1978, 113:133-135.
37. Abbott WC, Schiller WR, Long CL, et al. The effect of major thermal injury on plasma ketone body levels. JPEN J Parenter Enteral Nutr 1985, 9:153-158.
38. Ezzell RM, Carter EA, Yarmush ML, et al. Thermal injury-induced changes in the rat intestine brush border cytoskeleton. Surgery 1993, 114:591-597.
39. Eaves-Pyles T, Alexander JW Rapid and prolonged impairment of gut barrier function after thermal injury in mice. Shock 1998, 9:95-100.
40. Ramzy PI, Wolf SE, Irtun O, et al. Gut epithelial apoptosis after severe burn: Effects of gut hypoperfusion. J Am Coll Surg 2000, 190:281-287.
41. Deitch EA, Ma L, Ma JW, et al. Lethal burn-induced bacterial translocation: Role of genetic resistance. J Trauma 1989, 29:1480-1487.
42. Ma L, Ma JW, Deitch EA, et al. Genetic susceptibility to mucosal damage leads to bacterial translocation in a murine burn model. J Trauma 1989, 29:1245-1251.
43. 2 suppresses intestinal T cell function in thermal injury: A cause of enhanced bacterial translocation. Shock 2001, 16:183-188.
44. Ravindranath T, Al-Ghoul W, Namak S, et al. Effects of burn with and without Escherichia coli infection in rats on intestinal vs. splenic T-cell responses. Crit Care Med 2001, 29:2245-2250.
45. Fukuzuka K, Edwards CK, Clare-Salzer M, et al. Glucocorticoid and Fas ligand induced mucosal lymphocyte apoptosis after burn injury. J Trauma 2000, 49:710-716.
46. Fukuzuka K, Edwards CK, Clare-Salzler M, et al. Glucocorticoidinduced, caspase-dependent organ apoptosis early after burn injury. Am J Physiol Regul Integr Comp Physiol 2000, 278:R1005-R1018.
47. Fukuzuka K, Rosenberg JJ, Gaines GC, et al. Caspase-3-dependent organ apoptosis early after burn injury. Ann Surg 1999, 229:851-858.
48. Woodside KJ, Spies M, Wu XW, et al. Decreased lymphocyte apoptosis by anti-tumor necrosis factor antibody in Peyer's patches following severe burn. Shock 2003, 20:70-73.
49. Komano H, Fujiura Y, Kawaguchi M, et al. Homeostatic regulation of intestinal epithelia by intraepithelial γ$dL T cells. Proc Natl Acad Sci USA 1995, 92:6147-6151.
50. Nishiyama Y, Hamada H, Nonaka S, et al. Homeostatic regulation of intestinal villous epithelia by B lymphocytes. J Immunol 2002, 168:2626-2633.
51. Guy-Grand D, DiSanto JP, Henchoz P, et al. Small bowel enteropathy: Role of intraepithelial lymphocytes and of cytokines (IL-12, IFNγ, TNF) in the induction of epithelial cell death and renewal. Eur J Immunol 1998, 28:730-744.
52. 2 by subpopulations of guinea pig enterocytes: Effect of endotoxin and thermal injury. J Trauma 1996, 41:298-305.
53. Matsuo R, Kobayashi M, Herndon DN, et al. Interleukin-12 protects thermally injured mice from herpes simplex virus type 1 infection. J Leukoc Biol 1996, 59:623-630.
54. + suppressor T cells demonstrated in mice 1 day after thermal injury. J Trauma 1997, 42:635-640.
55. + cells. J Trauma 1997, 42:872-880.
56. Harrison TS, Seaton JF, Feller I Relationship of increased oxygen consumption to catecholamine excretion in thermal burns. Ann Surg 1967, 165:169-172.
57. Herndon DN, Parks DH Comparison of serial debridement and autografting and early massive excision with cadaver skin overlay in the treatment of large burns in children. J Trauma 1986, 26:149-152.
58. Goran MI, Peters EJ, Herndon DN, et al. Total energy expenditure in burned children using the doubly labeled water technique. Am J Physiol 1990, 259(4):E576-E585. part 1.
59. Goran MI, Broemeling L, Herndon DN, et al. Estimating energy requirements in burned children: A new approach derived from measurements of resting energy expenditure. Am J Clin Nutr 1991, 54:35-40.
60. Curreri PW Nutritional support of burn patients. World J Surg 1978, 2:215-222.
61. Adams MR, Kelly CH, Luterman A, et al. Nutritional requirements of patients with major burns. J Am Diet Assoc 1987, 65:415-417.
62. Hildreth MA, Herndon DN, Desai MH, et al. Caloric requirements of patients with burns under one year of age. J Burn Care Rehabil 1993, 14:108-112.
63. Hildreth MA, Herndon DN, Desai MH, et al. Caloric needs of adolescent patients with burns. J Burn Care Rehabil 1989, 10:523-526.
64. Hildreth MA, Herndon DN, Desai MH, et al. Current treatment reduces calories required to maintain weight in pediatric patients with burns. J Burn Care Rehabil 1990, 11:405-409.
65. Hart DW, Wolf SE, Herndon DN, et al. Energy expenditure and caloric balance after burn: Increased feeding leads to fat rather than lean mass accretion. Ann Surg 2002, 235:152-161.
66. Mochizuki H, Trocki O, Dominioni L, et al. Mechanism of prevention of postburn hypermetabolism and catabolism by early enteral feeding. Ann Surg 1984, 200:297-310.
67. McDonald WS, Sharp CW, Deitch EA Immediate enteral feeding in burn patients is safe and effective. Ann Surg 1991, 213:177-183.
68. Wolf SE, Jeschke MG, Rose JK, et al. Enteral feeding intolerance: An indicator of sepsis-associated mortality in burned children. Arch Surg 1997, 132:1310-1313.
69. Mentec H, Dupont H, Bocchetti M, et al. Upper digestive intolerance during enteral nutrition in critically ill patients: Frequency, risk factors, and complications. Crit Care Med 2001, 29:1955-1961.
70. Herndon DN, Barrow RE, Stein M, et al. Increased mortality with intravenous supplemental feeding in severely burned patients. J Burn Care Rehabil 1989, 10:309-313.
71. Herndon DN, Stein MD, Rutan TC, et al. Failure of TPN supplementation to improve liver function, immunity, and mortality in thermally injured patients. J Trauma 1987, 27:195-204.
72. DeBiasse MA, Wilmore DW What is optimal nutritional support?. New Horiz 1994, 2:122-130.
73. Streat SJ, Beddoe AH, Hill GL Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma 1987, 27:262-266.
74. Hart DW, Wolf SE, Zhang XJ, et al. Efficacy of a high-carbohydrate diet in catabolic illness. Crit Care Med 2001, 29:1318-1324.
75. Peterson JP, Long JM, Wilmore DW Nutritional efficacy, preparation and delivery of oral feedings to severely burned patients. Proc Am Burn Assoc 1976, 78.
76. Long JM, Wilmore DW, Mason AD, et al. Effect of carbohydrate and fat intake on nitrogen excretion during total intravenous feeding. Ann Surg 1977, 185:417-422.
77. McDougal WS, Wilmore DW, Pruitt BA Effect of intravenous near isosmotic nutrient infusions on nitrogen balance in critically ill injured patients. Surg Gynecol Obstet 1977, 145:408-414.
78. Ferrando AA, Chinkes DL, Wolf SE, et al. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg 1999, 229:11-18.
79. Zhang XJ, Chinkes DL, Wolf SE, et al. Insulin but not growth hormone stimulates protein anabolism in skin wound and muscle. Am J Physiol 1999, 276:E712-E720. (4 part 1).
80. Gottschlich MM, Alexander JW, Bower R Enteral nutrition in patients with burns or trauma. Enteral and Tube Feeding 1984, 306. WB Saunders, Philadelphia. J. Rombeau, M. Cladwell (Eds.).
81. Waymack JP, Herndon DN Nutritional support of the burned patient. World J Surg 1992, 16:80-86.
82. Biolo G, Tipton KD, Klein S, et al. An abundant supply of amino acids enhances the metabolic effect of exercise on muscle protein. Am J Physiol 1997, 273:E122-E129. (1 part 1).
83. Newsholme EA, Crabtree B, Ardawi MS The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells. Biosci Rep 1985, 5:393-400.
84. Windmueller HG, Spaeth AE Respiratory fuels and nitrogen metabolism in vivo in small intestine of fed rats. Quantitative importance of glutamine, glutamate, and aspartate. J Biol Chem 1980, 255:107-112.
85. Salgame P, Abrams JS, Clayberger C, et al. Differing lymphokine profiles of functional subsets of human CD4 and CDS T cell clones. Science 1991, 254:279-282.
86. Gianotti L, Alexander JW, Gennari R, et al. Oral glutamine decreases bacterial translocation and improves survival in experimental gut-origin sepsis. JPEN J Parenter Enteral Nutr 1995, 19:69-74.
87. Tenenhaus M, Hansbrough JF, Zapata-Sirvent RL, et al. Supplementation of an elemental enteral diet with alanyl-glutamine decreases bacterial translocation in burned mice. Burns 1994, 20:220-225.
88. Wischmeyer PE, Lynch J, Liedel J, et al. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: A prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med 2001, 29:2075-2080.
89. Houdijk AP, Rijnsburger ER, Jansen J, et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998, 352:772-776.
90. Hishikawa K, Nakaki T, Tsuda M, et al. Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man. Jpn Heart J 1992, 33:41-48.
91. Kirk SJ, Barbul A Role of arginine in trauma, sepsis, and immunity. JPEN J Parenter Enteral Nutr 1990, 14(5):226S-229S.
92. Saito H, Trocki O, Wang S Metabolic and immune effects of dietary arginine supplementation after bum. Arch Surg 1987, 122:784-789.
93. Cui XL, Iwasa M, Iwasa Y, et al. Arginine-supplemented diet decreases expression of inflammatory cytokines and improves survival in burned rats. JPEN J Parenter Enteral Nutr 2000, 24:89-96.
94. Mochizuki H, Trocki O, Dominioni L, et al. Effect of a diet rich in branched chain amino acids on severely burned guinea pigs. J Trauma 1986, 26:1077-1085.
95. Yu YM, Wagner DA, Walesreswski JC, et al. A kinetic study of leucine metabolism in severely burned patients. Comparison between a conventional and branched-chain amino acid-enriched nutritional therapy. Ann Surg 1988, 207:421-429.
96. Mayes T, Gottschlich MM, Warden GD Clinical nutrition protocols for continuous quality improvements in the outcomes of patients with burns. J Burn Care Rehabil 1997, 18:365-368.
97. Tanaka H, Matsuda H, Shimazaki S, et al. Reduced resuscitation fluid volume for second-degree burns with delayed initiation of ascorbic acid therapy. Arch Surg 1997, 132:158-161.
98. Barbul A, Regan MC Biology of wound healing. Surgical Basic Science 1993, 67. Mosby, St Louis. J.E. Fischer (Ed.).
99. Rock CL, Dechert RE, Khilnani R, et al. Carotenoids and antioxidant vitamins in patients after burn injury. J Burn Care Rehabil 1997, 18:269-278.
100. Klein GL, Langman CB, Herndon DN Vitamin D depletion following burn injury in children: A possible factor in post-burn osteopenia. J Trauma 2002, 52:346-350.
101. Larson DL, Maxwell R, Abston S, et al. Zinc deficiency in burned children. Plast Reconstr Surg 1970, 46:13-21.
102. Prasad AS Clinical, endocrinological, and biochemical effects of zinc deficiency. Clin Endocrinol Metab 1985, 14:567-589.
103. Boosalis MG, Solem LD, Ahrenholz DH, et al. Serum and urinary selenium levels in thermal injury. Burns Incl Therm Inj 1986, 12:236-240.
104. Barret JP, Herndon DN Modulation of inflammatory and catabolic responses in severely burned children by early burn wound excision in the first 24 hours. Arch Surg 2003, 138:127-132.
105. Xiao-Wu W, Herndon DN, Spies M, et al. Effects of delayed wound excision and grafting in severely burned children. Arch Surg 2002, 137:1049-1054.
106. McCampbell B, Wasif N, Rabbitts A, et al. Diabetes and burns: Retrospective cohort study. J Burn Care Rehabil 2002, 23:157-166.
107. Biolo G, Fleming RY, Maggi SP, et al. Inverse regulation of protein turnover and amino acid transport in skeletal muscle of hypercatabolic patients. J Clin Endocrinol Metab 2002, 87:3378-3384.
108. Ramzy PI, Wolf SE, Herndon DN Current status of anabolic hormone administration in human burn injury. JPEN J Parenter Enteral Nutr 1999, 23(6):S190-S194.
109. Gilpin DA, Barrow RE, Rutan RL, et al. Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg 1994, 220:19-24.
110. Herndon DN, Barrow RE, Kunkel KR, et al. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990, 212:424-429.
111. Ramirez RJ, Wolf SE, Barrow RE, Herndon DN Growth hormone treatment in pediatric burns: A safe therapeutic approach. Ann Surg 1998, 228:439-448.
112. Gore DC, Honeycutt D, Jahoor F, et al. Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch Surg 1990, 126:38-43.
113. Hart DW, Herndon DN, Klein G, et al. Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy. Ann Surg 2001, 233:827-834.
114. Dobashi H, Sato M, Tanaka T, et al. Growth hormone restores glucocorticoid-induced T cell suppression. FASEB J 2001, 15:1861-1863.
115. Brocardo MG, Schillaci R, Galeano A, et al. Early effects of insulin-like growth factor-1 in activated human T lymphocytes. J Leukoc Biol 2001, 70:297-305.
116. Public Communications from Pharmacia and Upjohn Pharmaceuticals and Rolf Gunnarsson, MD, to all industry and medical community involved with the use or potential use of recombinant human growth hormone, October 31, 1997.
117. Knox J, Demling R, Wilmore D, et al. Increased survival after major thermal injury: The effect of growth hormone therapy in adults. J Trauma 1995, 39:526-530.
118. Klein GL, Wolf SE, Langman CB, et al. Effects of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe bum injury. J Clin Endocrinol Metab 1998, 83:21-24.
119. Humbel RE Insulin-like growth factors I and II. Eur J Biochem 1990, 190:445-462.
120. Baxter RC Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex. J Clin Endocrinol Metab 1990, 70:1347-1353.
121. Baxter RC, Dai J Purification and characterization of the acid-labile subunit of rat serum insulin-like growth factor binding protein complex. Endocrinology 1994, 134:848-852.
122. Baxter RC, Martin JL Binding proteins for the insulin-like growth factors: Structure, regulation and function. Prog Growth Factor Res 1989, 1:49-68.
123. Cioffi WG, Gore DC, Rue LW, et al. Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury. Ann Surg 1994, 220:310-316.
124. Lewitt MS, Saunders H, Phuyal JL, et al. Complex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient rats. Endocrinology 1994, 134:2404-2409.
125. Herndon DN, Ramzy PI, DebRoy MA, et al. Muscle protein catabolism after severe burn: Effects of IGF-1/1GFBP-3 treatment. Ann Surg 1999, 229:713-720.
126. Debroy MA, Wolf SE, Zhang XJ, et al. Anabolic effects of insulin-like growth factor in combination with insulin-like growth factor binding protein-3 in severely burned adults. J Trauma 1999, 47:904-910.
127. Spies M, Wolf SE, Barrow RE, et al. Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children. Crit Care Med 2002, 30:83-88.
128. Wolfe SE, Woodside KJ, Ramirez RJ, et al. Insulin-like growth factor-1/insulin-like growth factor binding protein-3 alters lymphocyte responsiveness following severe burn. J Surg Res 2004, 117:255-261.
129. Thomas SJ, Morimoto K, Herndon DN, et al. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery 2002, 132:341-347.
130. Ferrando AA, Sheffield-Moore M, Wolf SE, et al. Testosterone administration in severe burns ameliorates muscle catabolism. Crit Care Med 2001, 29:1936-1942.
131. Hart DW, Wolf SE, Ramzy PI, et al. Anabolic effects of oxandrolone after severe burn. Ann Surg 2001, 233:556-564.
132. Demling RH, DeSanti L Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns. J Trauma 1997, 43:47-51.
133. Demling RH Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury. Burns 1999, 25:215-221.
134. Minifee PK, Barrow RE, Abston S, et al. Improved myocardial oxygen utilization following propranolol infusion in adolescents with postburn hypermetabolism. J Pediatr Surg 1989, 24:806-810.
135. Honeycutt D, Barrow R, Herndon D Cold stress response in patients with severe burns after beta-blockade. J Burn Care Rehabil 1992, 13:181-186. (2 part 1).
136. Herndon DN, Hart DW, Wolf SE, et al. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 2001, 345:1223-1229.
137. Hart DW, Wolf SE, Chinkes DL, et al. Beta-blockade and growth hormone after burn. Ann Surg 2002, 236:450-456.
138. Aarsland A, Chinkes D, Wolfe RR, et al. Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone. Rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged. Ann Surg 1996, 223:777-787.
139. Morio B, Irtun O, Herndon DN, et al. Propranolol decreases splanchnic triacylglycerol storage in burn patients receiving a high-carbohydrate diet. Ann Surg 2002, 236:218-225.
140. Barret JP, Jeschke MG, Herndon DN Fatty infiltration of the liver in severely burned pediatric patients: Autopsy findings and clinical implications. J Trauma 2001, 51:736-739.
141. Fang CH, James HJ, Ogle C, et al. Influence of burn injury on protein metabolism in different types of skeletal muscle and the role of glucocorticoids. J Am Coll Surg 1995, 180:33-42.
142. Lang CH, Nystrom GJ, Frost RA Burn-induced changes in IGF-I and IGF-binding proteins are partially glucocorticoid dependent. Am J Physiol Regul Integr Comp Physiol 2002, 282:R207-R215.